The World Health Organisation (WHO) said it's updating its guidelines on COVID-19 treatment to reflect the trial results of a common steroid in critical COVID-19 cases.
The preliminary results showed that dexamethasone reduced death rates by about one third for critically ill patients.
"This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support," WHO Director-General Tedros Adhanom Ghebreyesus said in a statement.
The agency said it will "coordinate a meta-analysis to increase our overall understanding of this intervention" and update the guidelines to "reflect how and when the drug should be used in COVID-19".
The drug has been used since the 1960s to reduce inflammation in diseases such as arthritis.
Gunshots fired in standoff at Philippine Senate over ICC suspect
Trump lands in China for Xi summit
Israeli airstrikes kill eight people on highway south of Beirut
Philippines' Senator says arrest imminent, urges public to block ICC transfer
UK's Starmer faces biggest challenge yet as resignation threat overshadows King's Speech
Israel steps up attacks on Gaza since Iran truce, as military says Hamas rearming
Trump says he does not need China's help to end Iran war
India's Modi cuts size of his motorcade to save fuel, source says
